OMB Individually Reported
CoreDF
Low riskExact public inventory row
Description
Current nonclinical review processes require manual extraction and analysis of sponsor findings from lengthy PDF study reports, creating inefficiencies in data quality assessment and regulatory timeline.
Detailed example
Sponsor findings from non-clinical study reports
AI / analytics pattern
Other
Automation level / stage
b) Pilot – The use case has been deployed in a limited test or pilot capacity.
Expected benefit
Expedites nonclinical review by extracting and organizing key safety findings from study reports, allowing FDA reviewers to focus on scientific evaluation and safety assessment rather than manual data extraction.
Controls / human review
ATO: Yes; PIA: Not published
Data needed
non-clinical study reports (PDFs)